pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,,
IL-6 signaling,INOH,2,IL6RB_HUMAN;JAK2_HUMAN,6 (6),0.000354,0.801,0.000561798,89
MAPK1 (ERK2) activation,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,9 (9),0.000841,0.801,,
Neddylation,Reactome,6,CUL3_HUMAN;FBXW9_HUMAN;PRS6A_HUMAN;LLR1_HUMAN;PSB11_HUMAN;DCA10_HUMAN,234 (235),0.000999,0.801,,
MAPK3 (ERK1) activation,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,10 (10),0.00105,0.801,,
Interleukin-27 signaling,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,10 (10),0.00105,0.801,,
LIF signaling,INOH,2,IL6RB_HUMAN;JAK2_HUMAN,10 (10),0.00105,0.801,,
Interleukin-6 signaling,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,11 (11),0.00128,0.837,,
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,Wikipathways,2,IL6RB_HUMAN;JAK2_HUMAN,13 (18),0.0018,1,,
IL-6-type cytokine receptor ligand interactions,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,15 (15),0.00241,1,,
Interleukin-12 family signaling,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,19 (19),0.00387,1,,
Mtb iron assimilation by chelation,Reactome,1,TRFL_HUMAN,1 (1),0.00493,1,,
Response of Mtb to phagocytosis,Reactome,1,TRFL_HUMAN,1 (1),0.00493,1,,
Latent infection of Homo sapiens with Mycobacterium tuberculosis,Reactome,1,TRFL_HUMAN,1 (1),0.00493,1,,
Interleukin-6 family signaling,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,22 (22),0.00518,1,,
NRF2-ARE regulation,Wikipathways,2,GSH1_HUMAN;CUL3_HUMAN,23 (23),0.00565,1,,
RAF-independent MAPK1/3 activation,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,23 (23),0.00565,1,,
IL11,NetPath,2,IL6RB_HUMAN;JAK2_HUMAN,23 (23),0.00565,1,,
IL27-mediated signaling events,PID,2,IL6RB_HUMAN;JAK2_HUMAN,26 (26),0.00719,1,,
RNA Polymerase III Transcription Initiation From Type 3 Promoter,Reactome,2,RPC1_HUMAN;SNPC2_HUMAN,29 (29),0.0089,1,,
D-<i>myo</i>-inositol (3_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,1,IPMK_HUMAN,2 (2),0.00983,1,,
RNA Polymerase III Transcription Initiation,Reactome,2,RPC1_HUMAN;SNPC2_HUMAN,37 (37),0.0142,1,,
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis V (from Ins(1_3_4)P3),HumanCyc,1,IPMK_HUMAN,3 (3),0.0147,1,,
glutathione biosynthesis,HumanCyc,1,GSH1_HUMAN,3 (3),0.0147,1,,
D-<i>myo</i>-inositol (1_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,1,IPMK_HUMAN,3 (3),0.0147,1,,
Optineurin and Myosin Phosphatase Negatively Regulate PLK1,Reactome,1,RAB8A_HUMAN,3 (3),0.0147,1,,
Hedgehog _on_ state,Reactome,2,GLI3_HUMAN;CUL3_HUMAN,38 (39),0.015,1,,
Oncostatin_M,NetPath,2,IL6RB_HUMAN;JAK2_HUMAN,38 (38),0.015,1,,
MAPK1/MAPK3 signaling,Reactome,4,IL6RB_HUMAN;PTPRA_HUMAN;CUL3_HUMAN;JAK2_HUMAN,202 (203),0.0174,1,,
RNA Polymerase III Abortive And Retractive Initiation,Reactome,2,RPC1_HUMAN;SNPC2_HUMAN,42 (42),0.0181,1,,
RNA Polymerase III Transcription,Reactome,2,RPC1_HUMAN;SNPC2_HUMAN,42 (42),0.0181,1,,
Splicing factor NOVA regulated synaptic proteins,Wikipathways,2,GABR2_HUMAN;NEO1_HUMAN,42 (42),0.0181,1,,
Glutamatergic synapse - Homo sapiens (human),KEGG,3,PA24E_HUMAN;SHAN2_HUMAN;SHAN3_HUMAN,114 (114),0.0186,1,,
Hedgehog Signaling Pathway,Wikipathways,2,GLI3_HUMAN;CUL3_HUMAN,43 (43),0.0189,1,,
IL-6 signaling pathway,Wikipathways,2,IL6RB_HUMAN;JAK2_HUMAN,43 (43),0.0189,1,,
Serotonin Receptor 2 and STAT3 Signaling,Wikipathways,1,JAK2_HUMAN,4 (4),0.0196,1,,
TPO signaling,INOH,1,JAK2_HUMAN,4 (4),0.0196,1,,
heme degradation,HumanCyc,1,HMOX2_HUMAN,4 (4),0.0196,1,,
Synthesis of IPs in the nucleus,Reactome,1,IPMK_HUMAN,4 (4),0.0196,1,,
Interleukin-11 Signaling Pathway,Wikipathways,2,IL6RB_HUMAN;JAK2_HUMAN,44 (44),0.0198,1,,
Proteasome - Homo sapiens (human),KEGG,2,PSB11_HUMAN;PRS6A_HUMAN,45 (45),0.0206,1,,
Aryl Hydrocarbon Receptor,Wikipathways,2,GSH1_HUMAN;NRIP1_HUMAN,46 (46),0.0215,1,,
IL6-mediated signaling events,PID,2,IL6RB_HUMAN;JAK2_HUMAN,47 (47),0.0224,1,,
Hedgehog signaling pathway - Homo sapiens (human),KEGG,2,GLI3_HUMAN;CUL3_HUMAN,47 (47),0.0224,1,,
Rett syndrome causing genes,Wikipathways,2,GABR2_HUMAN;SHAN3_HUMAN,48 (48),0.0233,1,,
ifn gamma signaling pathway,BioCarta,1,JAK2_HUMAN,5 (6),0.0244,1,,
Reelin signalling pathway,Reactome,1,RELN_HUMAN,5 (5),0.0244,1,,
Sperm:Oocyte Membrane Binding,Reactome,1,IZUM4_HUMAN,5 (5),0.0244,1,,
JAK STAT MolecularVariation 2,INOH,2,IL6RB_HUMAN;JAK2_HUMAN,50 (50),0.0251,1,,
Platelet degranulation ,Reactome,3,ALDOA_HUMAN;CD109_HUMAN;CAP1_HUMAN,128 (129),0.0252,1,,
Response to elevated platelet cytosolic Ca2+,Reactome,3,ALDOA_HUMAN;CD109_HUMAN;CAP1_HUMAN,133 (134),0.0278,1,,
MAPK family signaling cascades,Reactome,4,IL6RB_HUMAN;PTPRA_HUMAN;CUL3_HUMAN;JAK2_HUMAN,234 (237),0.0281,1,,
chondroitin and dermatan biosynthesis,HumanCyc,1,CHSS3_HUMAN,6 (6),0.0292,1,,
IFN gamma signaling,INOH,1,JAK2_HUMAN,6 (6),0.0292,1,,
IL-23 signaling,INOH,1,JAK2_HUMAN,6 (6),0.0292,1,,
Metal sequestration by antimicrobial proteins,Reactome,1,TRFL_HUMAN,6 (6),0.0292,1,,
Axon guidance,Reactome,5,RELN_HUMAN;PTPRA_HUMAN;NEO1_HUMAN;SHAN3_HUMAN;CAP1_HUMAN,356 (358),0.0306,1,,
Neurexins and neuroligins,Reactome,2,SHAN2_HUMAN;SHAN3_HUMAN,57 (57),0.032,1,,
Signaling by BRAF and RAF fusions,Reactome,2,MPRIP_HUMAN;JAK2_HUMAN,58 (58),0.0331,1,,
IL-3 signaling,INOH,1,JAK2_HUMAN,7 (7),0.034,1,,
GLI proteins bind promoters of Hh responsive genes to promote transcription,Reactome,1,GLI3_HUMAN,7 (7),0.034,1,,
inositol pyrophosphates biosynthesis,HumanCyc,1,IPMK_HUMAN,7 (7),0.034,1,,
IL-12 signaling,INOH,1,JAK2_HUMAN,7 (7),0.034,1,,
SHP2 signaling,PID,2,IL6RB_HUMAN;JAK2_HUMAN,59 (59),0.0341,1,,
Neuronal System,Reactome,5,GABR2_HUMAN;CAC1E_HUMAN;KCNG2_HUMAN;SHAN2_HUMAN;SHAN3_HUMAN,368 (368),0.0346,1,,
Oncogenic MAPK signaling,Reactome,2,MPRIP_HUMAN;JAK2_HUMAN,61 (61),0.0363,1,,
sucrose degradation,HumanCyc,1,ALDOA_HUMAN,8 (8),0.0387,1,,
Heme degradation,Reactome,1,HMOX2_HUMAN,8 (8),0.0387,1,,
stat3 signaling pathway,BioCarta,1,JAK2_HUMAN,8 (8),0.0387,1,,
Axonal growth inhibition (RHOA activation),Reactome,1,RTN4_HUMAN,8 (9),0.0387,1,,
Role of ABL in ROBO-SLIT signaling,Reactome,1,CAP1_HUMAN,8 (8),0.0387,1,,
Antigen processing: Ubiquitination & Proteasome degradation,Reactome,4,LLR1_HUMAN;CUL3_HUMAN;FBXW9_HUMAN;SH3R1_HUMAN,261 (264),0.0395,1,,
Oncostatin M Signaling Pathway,Wikipathways,2,IL6RB_HUMAN;JAK2_HUMAN,65 (65),0.0407,1,,
Myometrial Relaxation and Contraction Pathways,Wikipathways,3,CALD1_HUMAN;RXFP2_HUMAN;RYR2_HUMAN,155 (155),0.0409,1,,
Relaxin receptors,Reactome,1,RXFP2_HUMAN,9 (9),0.0435,1,,
no2-dependent il-12 pathway in nk cells,BioCarta,1,JAK2_HUMAN,9 (9),0.0435,1,,
Interleukin-23 signaling,Reactome,1,JAK2_HUMAN,9 (9),0.0435,1,,
p75NTR regulates axonogenesis,Reactome,1,RTN4_HUMAN,9 (10),0.0435,1,,
Beta-mercaptolactate-cysteine disulfiduria,SMPDB,1,GSH1_HUMAN,9 (9),0.0435,1,,
Cysteine Metabolism,SMPDB,1,GSH1_HUMAN,9 (9),0.0435,1,,
Cystinosis_ ocular nonnephropathic,SMPDB,1,GSH1_HUMAN,9 (9),0.0435,1,,
TP53 Regulates Metabolic Genes,Wikipathways,1,SESN3_HUMAN,9 (9),0.0435,1,,
Tgif disruption of Shh signaling,Wikipathways,1,GLI3_HUMAN,9 (9),0.0435,1,,
The NLRP3 inflammasome,Reactome,1,MEFV_HUMAN,10 (10),0.0482,1,,
regulation of spermatogenesis by crem,BioCarta,1,KIF17_HUMAN,10 (10),0.0482,1,,
Growth hormone signaling,INOH,1,JAK2_HUMAN,10 (10),0.0482,1,,
Hydrolysis of LPC,Reactome,1,PA24E_HUMAN,10 (11),0.0482,1,,
Interleukin-12 signaling,Reactome,1,JAK2_HUMAN,10 (10),0.0482,1,,
Mammary gland development pathway - Involution (Stage 4 of 4),Wikipathways,1,IL6RB_HUMAN,10 (10),0.0482,1,,
Hedgehog,INOH,2,GLI3_HUMAN;PRS6A_HUMAN,72 (72),0.049,1,,
IL6,NetPath,2,IL6RB_HUMAN;JAK2_HUMAN,74 (74),0.0514,1,,
epo signaling pathway,BioCarta,1,JAK2_HUMAN,11 (11),0.0529,1,,
Signaling by Leptin,Reactome,1,JAK2_HUMAN,11 (11),0.0529,1,,
Gamma-glutamyl-transpeptidase deficiency,SMPDB,1,GSH1_HUMAN,11 (11),0.0529,1,,
5-oxoprolinase deficiency,SMPDB,1,GSH1_HUMAN,11 (11),0.0529,1,,
Gamma-Glutamyltransferase Deficiency,SMPDB,1,GSH1_HUMAN,11 (11),0.0529,1,,
Glutathione Metabolism,SMPDB,1,GSH1_HUMAN,11 (11),0.0529,1,,
Nucleotide Excision Repair ,SMPDB,1,XPF_HUMAN,11 (11),0.0529,1,,
IL-5 signaling,INOH,1,JAK2_HUMAN,11 (11),0.0529,1,,
Glutathione Synthetase Deficiency,SMPDB,1,GSH1_HUMAN,11 (11),0.0529,1,,
5-Oxoprolinuria,SMPDB,1,GSH1_HUMAN,11 (11),0.0529,1,,
&gamma;-glutamyl cycle,HumanCyc,1,GSH1_HUMAN,12 (13),0.0576,1,,
Degradation of DVL,Reactome,1,CUL3_HUMAN,12 (12),0.0576,1,,
il 3 signaling pathway,BioCarta,1,JAK2_HUMAN,12 (12),0.0576,1,,
Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction),PharmGKB,1,CAC1E_HUMAN,12 (12),0.0576,1,,
Signaling by Hedgehog,Reactome,2,GLI3_HUMAN;CUL3_HUMAN,81 (82),0.0604,1,,
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,4,RELN_HUMAN;RAB8A_HUMAN;JAK2_HUMAN;COBA2_HUMAN,302 (302),0.0614,1,,
erythropoietin mediated neuroprotection through nf-kb,BioCarta,1,JAK2_HUMAN,13 (14),0.0622,1,,
il 6 signaling pathway,BioCarta,1,JAK2_HUMAN,13 (13),0.0622,1,,
Presynaptic depolarization and calcium channel opening,Reactome,1,CAC1E_HUMAN,13 (13),0.0622,1,,
chondroitin sulfate biosynthesis (late stages),HumanCyc,1,CHSS3_HUMAN,13 (13),0.0622,1,,
Mammary gland development pathway - Puberty (Stage 2 of 4),Wikipathways,1,NRIP1_HUMAN,13 (13),0.0622,1,,
Cell-type Dependent Selectivity of CCK2R Signaling,Wikipathways,1,RYR2_HUMAN,13 (13),0.0622,1,,
Prolactin receptor signaling,Reactome,1,JAK2_HUMAN,14 (14),0.0668,1,,
Glutathione synthesis and recycling,Reactome,1,GSH1_HUMAN,14 (15),0.0668,1,,
IL5-mediated signaling events,PID,1,JAK2_HUMAN,14 (14),0.0668,1,,
Regulation of IFNG signaling,Reactome,1,JAK2_HUMAN,14 (14),0.0668,1,,
chaperones modulate interferon signaling pathway,BioCarta,1,JAK2_HUMAN,14 (15),0.0668,1,,
Pentose Phosphate Pathway,SMPDB,1,ALDOA_HUMAN,14 (14),0.0668,1,,
Inositol Phosphate Metabolism,SMPDB,1,IPMK_HUMAN,14 (14),0.0668,1,,
Glucose-6-phosphate dehydrogenase deficiency,SMPDB,1,ALDOA_HUMAN,14 (14),0.0668,1,,
Ribose-5-phosphate isomerase deficiency,SMPDB,1,ALDOA_HUMAN,14 (14),0.0668,1,,
Transaldolase deficiency,SMPDB,1,ALDOA_HUMAN,14 (14),0.0668,1,,
PIWI-interacting RNA (piRNA) biogenesis,Reactome,1,DDX4_HUMAN,14 (14),0.0668,1,,
Protein-protein interactions at synapses,Reactome,2,SHAN2_HUMAN;SHAN3_HUMAN,88 (88),0.0698,1,,
GPCRs_ Class C Metabotropic glutamate_ pheromone,Wikipathways,1,GABR2_HUMAN,15 (15),0.0714,1,,
Interleukin-4 and 13 signaling,Reactome,1,JAK2_HUMAN,15 (15),0.0714,1,,
Inflammasomes,Reactome,1,MEFV_HUMAN,15 (15),0.0714,1,,
D-<i>myo</i>-inositol (1_3_4)-trisphosphate biosynthesis,HumanCyc,1,IPMK_HUMAN,15 (15),0.0714,1,,
il12 and stat4 dependent signaling pathway in th1 development,BioCarta,1,JAK2_HUMAN,15 (15),0.0714,1,,
GLI3 is processed to GLI3R by the proteasome,Reactome,1,GLI3_HUMAN,15 (15),0.0714,1,,
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian),HumanCyc,1,IPMK_HUMAN,15 (15),0.0714,1,,
Glycolysis,SMPDB,1,ALDOA_HUMAN,15 (15),0.0714,1,,
Glycogenosis_ Type VII. Tarui disease,SMPDB,1,ALDOA_HUMAN,15 (15),0.0714,1,,
Fanconi-bickel syndrome,SMPDB,1,ALDOA_HUMAN,15 (15),0.0714,1,,
Phytochemical activity on NRF2 transcriptional activation,Wikipathways,1,GSH1_HUMAN,15 (15),0.0714,1,,
RAF/MAP kinase cascade,Reactome,3,PTPRA_HUMAN;CUL3_HUMAN;JAK2_HUMAN,196 (197),0.0722,1,,
EGFR1,NetPath,5,CALD1_HUMAN;ALDOA_HUMAN;PTPRA_HUMAN;MPRIP_HUMAN;JAK2_HUMAN,455 (457),0.0729,1,,
Class I MHC mediated antigen processing & presentation,Reactome,4,LLR1_HUMAN;CUL3_HUMAN;FBXW9_HUMAN;SH3R1_HUMAN,321 (324),0.0733,1,,
RAB GEFs exchange GTP for GDP on RABs,Reactome,2,RAB8A_HUMAN;DEN5B_HUMAN,91 (91),0.074,1,,
cAMP signaling pathway - Homo sapiens (human),KEGG,3,GABR2_HUMAN;GLI3_HUMAN;RYR2_HUMAN,199 (199),0.0748,1,,
Hedgehog Signaling Pathway,Wikipathways,1,GLI3_HUMAN,16 (16),0.076,1,,
miR-targeted genes in adipocytes - TarBase,Wikipathways,1,CAP1_HUMAN,16 (34),0.076,1,,
Acyl chain remodelling of PI,Reactome,1,PA24E_HUMAN,17 (17),0.0806,1,,
Cyclophosphamide Pathway_ Pharmacodynamics,PharmGKB,1,XPF_HUMAN,17 (17),0.0806,1,,
dermatan sulfate biosynthesis,HumanCyc,1,CHSS3_HUMAN,17 (17),0.0806,1,,
Leptin Insulin Overlap,Wikipathways,1,JAK2_HUMAN,17 (17),0.0806,1,,
Pancreatic secretion - Homo sapiens (human),KEGG,2,RAB8A_HUMAN;RYR2_HUMAN,96 (96),0.0811,1,,
p75 NTR receptor-mediated signalling,Reactome,2,OBSCN_HUMAN;RTN4_HUMAN,96 (99),0.0811,1,,
Developmental Biology,Reactome,6,INVO_HUMAN;SHAN3_HUMAN;RELN_HUMAN;NEO1_HUMAN;CAP1_HUMAN;PTPRA_HUMAN,618 (620),0.0828,1,,
JAK STAT MolecularVariation 1,INOH,2,IL6RB_HUMAN;JAK2_HUMAN,98 (98),0.084,1,,
oxidative stress induced gene expression via nrf2,BioCarta,1,HMOX2_HUMAN,18 (18),0.0851,1,,
Fructose intolerance_ hereditary,SMPDB,1,ALDOA_HUMAN,18 (18),0.0851,1,,
Fructose and Mannose Degradation,SMPDB,1,ALDOA_HUMAN,18 (18),0.0851,1,,
Fructosuria,SMPDB,1,ALDOA_HUMAN,18 (18),0.0851,1,,
Potassium Channels,Reactome,2,GABR2_HUMAN;KCNG2_HUMAN,100 (100),0.087,1,,
LTF danger signal response pathway,Wikipathways,1,TRFL_HUMAN,19 (19),0.0896,1,,
Growth hormone receptor signaling,Reactome,1,JAK2_HUMAN,19 (19),0.0896,1,,
Metabolism of porphyrins,Reactome,1,HMOX2_HUMAN,19 (19),0.0896,1,,
RNA Polymerase III Chain Elongation,Reactome,1,RPC1_HUMAN,19 (19),0.0896,1,,
HH-Core,Signalink,1,GLI3_HUMAN,19 (19),0.0896,1,,
UCH proteinases,Reactome,2,PSB11_HUMAN;PRS6A_HUMAN,102 (102),0.09,1,,
Neutrophil degranulation,Reactome,5,TRFL_HUMAN;ALDOA_HUMAN;HMOX2_HUMAN;PRS6A_HUMAN;CAP1_HUMAN,488 (490),0.0919,1,,
JAK-STAT-Core,Signalink,2,IL6RB_HUMAN;JAK2_HUMAN,104 (104),0.093,1,,
Chondroitin sulfate biosynthesis,Reactome,1,CHSS3_HUMAN,20 (20),0.0941,1,,
Canonical Wnt signaling pathway,PID,1,CUL3_HUMAN,20 (20),0.0941,1,,
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human),KEGG,1,CHSS3_HUMAN,20 (20),0.0941,1,,
lissencephaly gene (lis1) in neuronal migration and development,BioCarta,1,RELN_HUMAN,20 (20),0.0941,1,,
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,1,IPMK_HUMAN,20 (20),0.0941,1,,
HH-Ncore,Signalink,1,CUL3_HUMAN,20 (20),0.0941,1,,
Glutathione metabolism,Wikipathways,1,GSH1_HUMAN,20 (20),0.0941,1,,
Hereditary leiomyomatosis and renal cell carcinoma pathway,Wikipathways,1,CUL3_HUMAN,20 (20),0.0941,1,,
Th17 cell differentiation - Homo sapiens (human),KEGG,2,IL6RB_HUMAN;JAK2_HUMAN,107 (107),0.0975,1,,
TSLP,NetPath,1,JAK2_HUMAN,21 (21),0.0986,1,,
downregulated of mta-3 in er-negative breast tumors,BioCarta,1,ALDOA_HUMAN,21 (21),0.0986,1,,
chondroitin sulfate biosynthesis,HumanCyc,1,CHSS3_HUMAN,21 (21),0.0986,1,,
VxPx cargo-targeting to cilium,Reactome,1,RAB8A_HUMAN,21 (21),0.0986,1,,
inhibition of cellular proliferation by gleevec,BioCarta,1,JAK2_HUMAN,22 (22),0.103,1,,
Gluconeogenesis,SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Glycogenosis_ Type IA. Von gierke disease,SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Glycogenosis_ Type IC,SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Inositol Metabolism,SMPDB,1,IPMK_HUMAN,22 (22),0.103,1,,
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Triosephosphate isomerase,SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Fructose-1_6-diphosphatase deficiency,SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Glycogenosis_ Type IB,SMPDB,1,ALDOA_HUMAN,22 (22),0.103,1,,
Transcription factor regulation in adipogenesis,Wikipathways,1,NRIP1_HUMAN,22 (22),0.103,1,,
The human immune response to tuberculosis,Wikipathways,1,JAK2_HUMAN,22 (22),0.103,1,,
Glycolysis Pathway D (2),Wikipathways,1,ALDOA_HUMAN,23 (23),0.107,1,,
growth hormone signaling pathway,BioCarta,1,JAK2_HUMAN,23 (23),0.107,1,,
Regulation of RAS by GAPs,Reactome,1,CUL3_HUMAN,23 (24),0.107,1,,
Acyl chain remodelling of PS,Reactome,1,PA24E_HUMAN,23 (23),0.107,1,,
how progesterone initiates the oocyte maturation,BioCarta,1,CAP1_HUMAN,23 (23),0.107,1,,
Doxorubicin Pathway (Cardiomyocyte Cell)_ Pharmacodynamics,PharmGKB,1,RYR2_HUMAN,23 (24),0.107,1,,
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,1,GSH1_HUMAN,23 (23),0.107,1,,
Homocarnosinosis,SMPDB,1,GSH1_HUMAN,23 (23),0.107,1,,
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,1,GSH1_HUMAN,23 (23),0.107,1,,
Succinic semialdehyde dehydrogenase deficiency,SMPDB,1,GSH1_HUMAN,23 (23),0.107,1,,
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,1,GSH1_HUMAN,23 (23),0.107,1,,
Glutamate Metabolism,SMPDB,1,GSH1_HUMAN,23 (23),0.107,1,,
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Wikipathways,1,GSH1_HUMAN,23 (23),0.107,1,,
Spinal Cord Injury,Wikipathways,2,PTPRA_HUMAN;RTN4_HUMAN,115 (117),0.11,1,,
RUNX2 regulates osteoblast differentiation,Reactome,1,GLI3_HUMAN,24 (24),0.112,1,,
Plexin-D1 Signaling,PID,1,SEM3C_HUMAN,24 (24),0.112,1,,
RNA Polymerase III Transcription Termination,Reactome,1,RPC1_HUMAN,24 (24),0.112,1,,
glycolysis,HumanCyc,1,ALDOA_HUMAN,24 (25),0.112,1,,
Pentose phosphate cycle,INOH,1,ALDOA_HUMAN,24 (24),0.112,1,,
Physiological and Pathological Hypertrophy of the Heart,Wikipathways,1,IL6RB_HUMAN,24 (24),0.112,1,,
miRNA regulation of p53 pathway in prostate cancer,Wikipathways,1,SESN3_HUMAN,24 (32),0.112,1,,
TCR,NetPath,3,PTPRA_HUMAN;HNRH3_HUMAN;PHLB3_HUMAN,241 (245),0.116,1,,
RAF activation,Reactome,1,JAK2_HUMAN,25 (25),0.116,1,,
alpha-Linolenic acid metabolism - Homo sapiens (human),KEGG,1,PA24E_HUMAN,25 (25),0.116,1,,
Hedgehog,NetPath,1,GLI3_HUMAN,25 (25),0.116,1,,
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Reactome,1,GABR2_HUMAN,25 (25),0.116,1,,
Activation of G protein gated Potassium channels,Reactome,1,GABR2_HUMAN,25 (25),0.116,1,,
G protein gated Potassium channels,Reactome,1,GABR2_HUMAN,25 (25),0.116,1,,
tpo signaling pathway,BioCarta,1,JAK2_HUMAN,25 (25),0.116,1,,
gluconeogenesis,HumanCyc,1,ALDOA_HUMAN,25 (26),0.116,1,,
Vascular smooth muscle contraction - Homo sapiens (human),KEGG,2,CALD1_HUMAN;PA24E_HUMAN,121 (121),0.12,1,,
EPO Receptor Signaling,Wikipathways,1,JAK2_HUMAN,26 (26),0.121,1,,
Fertilization,Reactome,1,IZUM4_HUMAN,26 (26),0.121,1,,
S1P3 pathway,PID,1,JAK2_HUMAN,26 (26),0.121,1,,
Glutamate Glutamine metabolism,INOH,1,GSH1_HUMAN,26 (27),0.121,1,,
miR-targeted genes in squamous cell - TarBase,Wikipathways,2,DHX57_HUMAN;RTN4_HUMAN,122 (158),0.121,1,,
IL3-mediated signaling events,PID,1,JAK2_HUMAN,27 (28),0.125,1,,
Interleukin receptor SHC signaling,Reactome,1,JAK2_HUMAN,27 (27),0.125,1,,
Rab regulation of trafficking,Reactome,2,RAB8A_HUMAN;DEN5B_HUMAN,126 (126),0.128,1,,
miR-targeted genes in leukocytes - TarBase,Wikipathways,2,RTN4_HUMAN;CAP1_HUMAN,126 (154),0.128,1,,
Transcriptional Regulation by MECP2,Wikipathways,1,GRIN1_HUMAN,28 (30),0.129,1,,
Acyl chain remodelling of PC,Reactome,1,PA24E_HUMAN,28 (28),0.129,1,,
Reelin signaling pathway,PID,1,RELN_HUMAN,28 (28),0.129,1,,
role of erbb2 in signal transduction and oncology,BioCarta,1,JAK2_HUMAN,28 (28),0.129,1,,
RNA Polymerase III Transcription Initiation From Type 2 Promoter,Reactome,1,RPC1_HUMAN,28 (28),0.129,1,,
Linoleic acid metabolism - Homo sapiens (human),KEGG,1,PA24E_HUMAN,29 (29),0.134,1,,
Hippo signaling pathway - multiple species - Homo sapiens (human),KEGG,1,FRMD6_HUMAN,29 (29),0.134,1,,
CDO in myogenesis,Reactome,1,NEO1_HUMAN,29 (29),0.134,1,,
Myogenesis,Reactome,1,NEO1_HUMAN,29 (29),0.134,1,,
RNA Polymerase III Transcription Initiation From Type 1 Promoter,Reactome,1,RPC1_HUMAN,29 (29),0.134,1,,
PDGFR-beta pathway,Wikipathways,1,JAK2_HUMAN,29 (29),0.134,1,,
Adipogenesis,Wikipathways,2,NRIP1_HUMAN;IL6RB_HUMAN,130 (131),0.134,1,,
Platelet activation_ signaling and aggregation,Reactome,3,ALDOA_HUMAN;CD109_HUMAN;CAP1_HUMAN,259 (260),0.135,1,,
Angiopoietin Like Protein 8 Regulatory Pathway,Wikipathways,2,SESN3_HUMAN;CAP1_HUMAN,131 (131),0.136,1,,
Retinoic acid receptors-mediated signaling,PID,1,NRIP1_HUMAN,30 (30),0.138,1,,
Pentose phosphate pathway - Homo sapiens (human),KEGG,1,ALDOA_HUMAN,30 (30),0.138,1,,
Fructose Mannose metabolism,INOH,1,ALDOA_HUMAN,30 (30),0.138,1,,
Acyl chain remodelling of PE,Reactome,1,PA24E_HUMAN,30 (30),0.138,1,,
Proteoglycan biosynthesis,EHMN,1,CHSS3_HUMAN,30 (30),0.138,1,,
ErbB4 signaling events,PID,1,JAK2_HUMAN,31 (31),0.142,1,,
Lissencephaly gene (LIS1) in neuronal migration and development,PID,1,RELN_HUMAN,31 (31),0.142,1,,
RNA polymerase - Homo sapiens (human),KEGG,1,RPC1_HUMAN,31 (31),0.142,1,,
Inwardly rectifying K+ channels,Reactome,1,GABR2_HUMAN,31 (31),0.142,1,,
IL17 signaling pathway,Wikipathways,1,JAK2_HUMAN,31 (31),0.142,1,,
Gastric Cancer Network 2,Wikipathways,1,CTF18_HUMAN,31 (32),0.142,1,,
Trans-sulfuration and one carbon metabolism,Wikipathways,1,GSH1_HUMAN,31 (31),0.142,1,,
Ovarian Infertility Genes,Wikipathways,1,NRIP1_HUMAN,31 (31),0.142,1,,
Tumor suppressor activity of SMARCB1,Wikipathways,1,GLI3_HUMAN,31 (31),0.142,1,,
miR-targeted genes in lymphocytes - TarBase,Wikipathways,4,HXA5_HUMAN;DHX57_HUMAN;RTN4_HUMAN;CAP1_HUMAN,409 (489),0.142,1,,
RUNX2 regulates bone development,Reactome,1,GLI3_HUMAN,32 (32),0.146,1,,
Translocation of GLUT4 to the plasma membrane,Reactome,1,RAB8A_HUMAN,32 (32),0.146,1,,
Death Receptor Signalling,Reactome,2,OBSCN_HUMAN;RTN4_HUMAN,138 (141),0.148,1,,
Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human),KEGG,2,IL6RB_HUMAN;JAK2_HUMAN,139 (139),0.15,1,,
EPO signaling pathway,PID,1,JAK2_HUMAN,33 (33),0.151,1,,
bioactive peptide induced signaling pathway,BioCarta,1,JAK2_HUMAN,33 (33),0.151,1,,
Fructose and mannose metabolism - Homo sapiens (human),KEGG,1,ALDOA_HUMAN,33 (33),0.151,1,,
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),Wikipathways,1,JAK2_HUMAN,33 (33),0.151,1,,
Pregnane X Receptor pathway,Wikipathways,1,NRIP1_HUMAN,33 (33),0.151,1,,
Oxidative Stress,Wikipathways,1,GSH1_HUMAN,33 (33),0.151,1,,
Alpha4 beta1 integrin signaling events,PID,1,PTPRA_HUMAN,34 (34),0.155,1,,
Gluconeogenesis,Reactome,1,ALDOA_HUMAN,34 (35),0.155,1,,
Smooth Muscle Contraction,Reactome,1,CALD1_HUMAN,35 (35),0.159,1,,
Circadian Clock,Reactome,1,NRIP1_HUMAN,35 (35),0.159,1,,
RET signaling,Reactome,1,SHAN3_HUMAN,35 (35),0.159,1,,
Signaling by RAS mutants,Reactome,1,JAK2_HUMAN,36 (36),0.163,1,,
Calcium Regulation in the Cardiac Cell,Wikipathways,2,CAC1E_HUMAN;RYR2_HUMAN,149 (149),0.167,1,,
HDR through Single Strand Annealing (SSA),Reactome,1,XPF_HUMAN,37 (37),0.167,1,,
Type II interferon signaling (IFNG),Wikipathways,1,JAK2_HUMAN,37 (37),0.167,1,,
IL23-mediated signaling events,PID,1,JAK2_HUMAN,37 (37),0.167,1,,
GMCSF-mediated signaling events,PID,1,JAK2_HUMAN,37 (37),0.167,1,,
Validated transcriptional targets of AP1 family members Fra1 and Fra2,PID,1,INVO_HUMAN,37 (37),0.167,1,,
G13 Signaling Pathway,Wikipathways,1,SH3R1_HUMAN,38 (38),0.171,1,,
Glutathione conjugation,Reactome,1,GSH1_HUMAN,38 (39),0.171,1,,
Interleukin-2 family signaling,Reactome,1,JAK2_HUMAN,38 (38),0.171,1,,
Signaling by moderate kinase activity BRAF mutants,Reactome,1,JAK2_HUMAN,38 (38),0.171,1,,
Paradoxical activation of RAF signaling by kinase inactive BRAF,Reactome,1,JAK2_HUMAN,38 (38),0.171,1,,
Oxytocin signaling pathway - Homo sapiens (human),KEGG,2,PA24E_HUMAN;RYR2_HUMAN,152 (152),0.172,1,,
Signaling events regulated by Ret tyrosine kinase,PID,1,SHAN3_HUMAN,39 (39),0.175,1,,
Association of TriC/CCT with target proteins during biosynthesis,Reactome,1,FBXW9_HUMAN,39 (39),0.175,1,,
Activation of GABAB receptors,Reactome,1,GABR2_HUMAN,39 (39),0.175,1,,
GABA B receptor activation,Reactome,1,GABR2_HUMAN,39 (39),0.175,1,,
Integrated Lung Cancer Pathway,Wikipathways,1,JAK2_HUMAN,39 (40),0.175,1,,
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,Wikipathways,2,ALDOA_HUMAN;RYR2_HUMAN,156 (159),0.179,1,,
Ferroptosis,Wikipathways,1,GSH1_HUMAN,40 (40),0.18,1,,
Fanconi Anemia Pathway,Reactome,1,XPF_HUMAN,40 (41),0.18,1,,
ErbB2/ErbB3 signaling events,PID,1,JAK2_HUMAN,40 (40),0.18,1,,
Ferroptosis - Homo sapiens (human),KEGG,1,GSH1_HUMAN,40 (40),0.18,1,,
Class C/3 (Metabotropic glutamate/pheromone receptors),Reactome,1,GABR2_HUMAN,40 (40),0.18,1,,
IL-5 Signaling Pathway,Wikipathways,1,JAK2_HUMAN,40 (40),0.18,1,,
Immune System,Reactome,12,ALDOA_HUMAN;CUL3_HUMAN;FBXW9_HUMAN;PRS6A_HUMAN;LLR1_HUMAN;MEFV_HUMAN;IL6RB_HUMAN;CAP1_HUMAN;TRFL_HUMAN;HMOX2_HUMAN;SH3R1_HUMAN;JAK2_HUMAN,1825 (1840),0.18,1,,
Gastrin,NetPath,1,JAK2_HUMAN,41 (41),0.184,1,,
phospholipases,HumanCyc,1,PA24E_HUMAN,41 (41),0.184,1,,
Aurora B signaling,PID,1,CUL3_HUMAN,41 (41),0.184,1,,
Nucleotide-binding Oligomerization Domain (NOD) pathway,Wikipathways,1,MEFV_HUMAN,41 (41),0.184,1,,
Inositol phosphate metabolism,INOH,1,IPMK_HUMAN,41 (41),0.184,1,,
Netrin-1 signaling,Reactome,1,NEO1_HUMAN,41 (41),0.184,1,,
Dual Incision in GG-NER,Reactome,1,XPF_HUMAN,41 (41),0.184,1,,
Intraflagellar transport,Reactome,1,KIF17_HUMAN,41 (41),0.184,1,,
Porphyrin and chlorophyll metabolism - Homo sapiens (human),KEGG,1,HMOX2_HUMAN,42 (42),0.188,1,,
IFN-gamma pathway,PID,1,JAK2_HUMAN,42 (42),0.188,1,,
actions of nitric oxide in the heart,BioCarta,1,RYR2_HUMAN,42 (42),0.188,1,,
Hair Follicle Development- Induction (Part 1 of 3),Wikipathways,1,INVO_HUMAN,42 (42),0.188,1,,
JAK-STAT signaling pathway - Homo sapiens (human),KEGG,2,IL6RB_HUMAN;JAK2_HUMAN,162 (162),0.19,1,,
Necroptosis - Homo sapiens (human),KEGG,2,PA24E_HUMAN;JAK2_HUMAN,162 (162),0.19,1,,
Syndecan-1-mediated signaling events,PID,1,COBA2_HUMAN,43 (43),0.192,1,,
Hedgehog _off_ state,Reactome,1,GLI3_HUMAN,43 (44),0.192,1,,
Signaling by SCF-KIT,Reactome,1,JAK2_HUMAN,43 (43),0.192,1,,
Formation of Incision Complex in GG-NER,Reactome,1,XPF_HUMAN,43 (43),0.192,1,,
Collagen chain trimerization,Reactome,1,COBA2_HUMAN,44 (44),0.196,1,,
FOXA1 transcription factor network,PID,1,NRIP1_HUMAN,44 (44),0.196,1,,
Cyclin D associated events in G1,Reactome,1,JAK2_HUMAN,44 (44),0.196,1,,
G1 Phase,Reactome,1,JAK2_HUMAN,44 (44),0.196,1,,
Voltage gated Potassium channels,Reactome,1,KCNG2_HUMAN,44 (44),0.196,1,,
Interleukin-3_ 5 and GM-CSF signaling,Reactome,1,JAK2_HUMAN,44 (44),0.196,1,,
JAK STAT pathway and regulation,INOH,3,IL6RB_HUMAN;JAK2_HUMAN;PRS6A_HUMAN,310 (310),0.196,1,,
Glycolysis and Gluconeogenesis,Wikipathways,1,ALDOA_HUMAN,45 (45),0.2,1,,
Glycolysis Gluconeogenesis,INOH,1,ALDOA_HUMAN,45 (46),0.2,1,,
Insulin Pathway,PID,1,PTPRA_HUMAN,46 (46),0.204,1,,
Regulation of RhoA activity,PID,1,OBSCN_HUMAN,46 (48),0.204,1,,
Type II diabetes mellitus - Homo sapiens (human),KEGG,1,CAC1E_HUMAN,46 (46),0.204,1,,
Regulation of Microtubule Cytoskeleton,Wikipathways,1,PTPRA_HUMAN,46 (46),0.204,1,,
Influenza A - Homo sapiens (human),KEGG,2,NXF3_HUMAN;JAK2_HUMAN,171 (171),0.206,1,,
Trans-sulfuration pathway,Wikipathways,1,GSH1_HUMAN,47 (47),0.207,1,,
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle,HumanCyc,1,ALDOA_HUMAN,47 (48),0.207,1,,
TBC/RABGAPs,Reactome,1,RAB8A_HUMAN,47 (47),0.207,1,,
Cysteine and methionine metabolism - Homo sapiens (human),KEGG,1,GSH1_HUMAN,47 (47),0.207,1,,
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Reactome,1,MEFV_HUMAN,47 (47),0.207,1,,
Nucleotide excision repair - Homo sapiens (human),KEGG,1,XPF_HUMAN,47 (47),0.207,1,,
Ether lipid metabolism - Homo sapiens (human),KEGG,1,PA24E_HUMAN,47 (47),0.207,1,,
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway,Wikipathways,1,JAK2_HUMAN,47 (47),0.207,1,,
IL5,NetPath,1,JAK2_HUMAN,48 (48),0.211,1,,
Notch-mediated HES/HEY network,PID,1,JAK2_HUMAN,48 (48),0.211,1,,
Hedgehog signaling events mediated by Gli proteins,PID,1,GLI3_HUMAN,48 (48),0.211,1,,
G beta:gamma signalling through PI3Kgamma,Reactome,1,JAK2_HUMAN,48 (48),0.211,1,,
Ovarian steroidogenesis - Homo sapiens (human),KEGG,1,PA24E_HUMAN,49 (49),0.215,1,,
Inositol phosphate metabolism,Reactome,1,IPMK_HUMAN,49 (50),0.215,1,,
IL-3 Signaling Pathway,Wikipathways,1,JAK2_HUMAN,49 (49),0.215,1,,
Chondroitin sulfate/dermatan sulfate metabolism,Reactome,1,CHSS3_HUMAN,50 (50),0.219,1,,
IL3,NetPath,1,JAK2_HUMAN,51 (51),0.223,1,,
Mineral absorption - Homo sapiens (human),KEGG,1,HMOX2_HUMAN,51 (51),0.223,1,,
G-protein beta:gamma signalling,Reactome,1,JAK2_HUMAN,51 (51),0.223,1,,
Cargo trafficking to the periciliary membrane,Reactome,1,RAB8A_HUMAN,51 (51),0.223,1,,
Signaling events mediated by Stem cell factor receptor (c-Kit),PID,1,JAK2_HUMAN,52 (52),0.227,1,,
Ion homeostasis,Reactome,1,RYR2_HUMAN,52 (52),0.227,1,,
mechanism of gene regulation by peroxisome proliferators via ppara,BioCarta,1,NRIP1_HUMAN,52 (52),0.227,1,,
One carbon metabolism and related pathways,Wikipathways,1,GSH1_HUMAN,52 (52),0.227,1,,
Signaling events mediated by PTP1B,PID,1,JAK2_HUMAN,53 (53),0.231,1,,
Apoptosis-related network due to altered Notch3 in ovarian cancer,Wikipathways,1,GSH1_HUMAN,53 (53),0.231,1,,
Calcium signaling pathway - Homo sapiens (human),KEGG,2,CAC1E_HUMAN;RYR2_HUMAN,185 (186),0.231,1,,
Herpes simplex infection - Homo sapiens (human),KEGG,2,NXF3_HUMAN;JAK2_HUMAN,185 (185),0.231,1,,
Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human),KEGG,2,IL6RB_HUMAN;JAK2_HUMAN,186 (186),0.233,1,,
Post-translational protein modification,Reactome,9,CUL3_HUMAN;FBXW9_HUMAN;PRS6A_HUMAN;UROM_HUMAN;LLR1_HUMAN;PSB11_HUMAN;RAB8A_HUMAN;CD109_HUMAN;DCA10_HUMAN,1377 (1383),0.234,1,,
Fanconi anemia pathway - Homo sapiens (human),KEGG,1,XPF_HUMAN,54 (54),0.235,1,,
Arginine Proline metabolism,INOH,1,GSH1_HUMAN,54 (55),0.235,1,,
IL-4 Signaling Pathway,Wikipathways,1,JAK2_HUMAN,54 (54),0.235,1,,
Cilium Assembly,Reactome,2,KIF17_HUMAN;RAB8A_HUMAN,187 (187),0.235,1,,
Complex I biogenesis,Reactome,1,NDUF5_HUMAN,55 (55),0.238,1,,
GABA receptor activation,Reactome,1,GABR2_HUMAN,55 (55),0.238,1,,
Antiarrhythmic Pathway_ Pharmacodynamics,PharmGKB,1,RYR2_HUMAN,55 (55),0.238,1,,
Glutathione metabolism - Homo sapiens (human),KEGG,1,GSH1_HUMAN,56 (56),0.242,1,,
EGF-Ncore,Signalink,1,SH3R1_HUMAN,57 (57),0.246,1,,
Iron uptake and transport,Reactome,1,HMOX2_HUMAN,58 (58),0.25,1,,
Notch,NetPath,1,JAK2_HUMAN,58 (59),0.25,1,,
Celecoxib Pathway_ Pharmacodynamics,PharmGKB,1,CAC1E_HUMAN,58 (58),0.25,1,,
Preimplantation Embryo,Wikipathways,1,DPPA3_HUMAN,58 (59),0.25,1,,
Muscle contraction,Reactome,2,CALD1_HUMAN;RYR2_HUMAN,195 (195),0.25,1,,
VEGF signaling pathway - Homo sapiens (human),KEGG,1,PA24E_HUMAN,59 (59),0.253,1,,
NRAGE signals death through JNK,Reactome,1,OBSCN_HUMAN,59 (61),0.253,1,,
NCAM signaling for neurite out-growth,Reactome,1,PTPRA_HUMAN,59 (59),0.253,1,,
Kit receptor signaling pathway,Wikipathways,1,JAK2_HUMAN,59 (59),0.253,1,,
ATF-2 transcription factor network,PID,1,CUL3_HUMAN,60 (60),0.257,1,,
Long-term depression - Homo sapiens (human),KEGG,1,PA24E_HUMAN,60 (60),0.257,1,,
Notch Signaling Pathway,Wikipathways,1,JAK2_HUMAN,61 (61),0.261,1,,
Penbutolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Coregulation of Androgen receptor activity,PID,1,NRIP1_HUMAN,61 (61),0.261,1,,
Disopyramide Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Procainamide (Antiarrhythmic) Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Fosphenytoin (Antiarrhythmic) Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Bopindolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Timolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Carteolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Bevantolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Practolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Dobutamine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Isoprenaline Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Arbutamine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Amiodarone Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Levobunolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Metipranolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Mexiletine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Quinidine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Sotalol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Betaxolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Atenolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Alprenolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Acebutolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Muscle/Heart Contraction,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Diltiazem Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Propranolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Pindolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Oxprenolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Metoprolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Esmolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Bisoprolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Bupranolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Nebivolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Amlodipine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Verapamil Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Nitrendipine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Nisoldipine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Nimodipine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Ibutilide Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Tocainide Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Flecainide Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Isradipine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Nifedipine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Felodipine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Nadolol Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
Epinephrine Action Pathway,SMPDB,1,RYR2_HUMAN,61 (61),0.261,1,,
TLR JNK,INOH,1,PRS6A_HUMAN,62 (62),0.264,1,,
Leptin,NetPath,1,JAK2_HUMAN,62 (62),0.264,1,,
IL-1 JNK,INOH,1,PRS6A_HUMAN,62 (62),0.264,1,,
Carvedilol Action Pathway,SMPDB,1,RYR2_HUMAN,62 (62),0.264,1,,
Labetalol Action Pathway,SMPDB,1,RYR2_HUMAN,62 (62),0.264,1,,
Endochondral Ossification,Wikipathways,1,GLI3_HUMAN,63 (63),0.268,1,,
IL4,NetPath,1,JAK2_HUMAN,63 (63),0.268,1,,
TLR p38,INOH,1,PRS6A_HUMAN,63 (63),0.268,1,,
Arachidonic acid metabolism - Homo sapiens (human),KEGG,1,PA24E_HUMAN,63 (63),0.268,1,,
IL12-mediated signaling events,PID,1,JAK2_HUMAN,63 (65),0.268,1,,
Integrins in angiogenesis,PID,1,COBA2_HUMAN,63 (63),0.268,1,,
Cytosolic DNA-sensing pathway - Homo sapiens (human),KEGG,1,RPC1_HUMAN,63 (63),0.268,1,,
Basal cell carcinoma - Homo sapiens (human),KEGG,1,GLI3_HUMAN,63 (63),0.268,1,,
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,1,RYR2_HUMAN,63 (63),0.268,1,,
Proteasome Degradation,Wikipathways,1,PRS6A_HUMAN,63 (64),0.268,1,,
MECP2 and Associated Rett Syndrome,Wikipathways,1,GRIN1_HUMAN,63 (63),0.268,1,,
Pathways Affected in Adenoid Cystic Carcinoma,Wikipathways,1,SRCAP_HUMAN,63 (63),0.268,1,,
Validated nuclear estrogen receptor alpha network,PID,1,NRIP1_HUMAN,64 (64),0.272,1,,
Endothelins,PID,1,JAK2_HUMAN,64 (64),0.272,1,,
IL-1 NFkB,INOH,1,PRS6A_HUMAN,64 (64),0.272,1,,
IL4-mediated signaling events,PID,1,JAK2_HUMAN,65 (65),0.275,1,,
DroToll-like,INOH,1,PRS6A_HUMAN,65 (65),0.275,1,,
Mitochondrial protein import,Reactome,1,TIM10_HUMAN,65 (65),0.275,1,,
RAB geranylgeranylation,Reactome,1,RAB8A_HUMAN,65 (65),0.275,1,,
Beta1 integrin cell surface interactions,PID,1,COBA2_HUMAN,66 (66),0.279,1,,
HIF-1-alpha transcription factor network,PID,1,ALDOA_HUMAN,66 (66),0.279,1,,
Signaling by ROBO receptors,Reactome,1,CAP1_HUMAN,66 (66),0.279,1,,
IL-1 p38,INOH,1,PRS6A_HUMAN,66 (66),0.279,1,,
Human Thyroid Stimulating Hormone (TSH) signaling pathway,Wikipathways,1,JAK2_HUMAN,66 (66),0.279,1,,
AGE-RAGE pathway,Wikipathways,1,JAK2_HUMAN,66 (66),0.279,1,,
TNF,INOH,1,PRS6A_HUMAN,67 (67),0.282,1,,
Fc epsilon RI signaling pathway - Homo sapiens (human),KEGG,1,PA24E_HUMAN,67 (68),0.282,1,,
Collagen biosynthesis and modifying enzymes,Reactome,1,COBA2_HUMAN,68 (68),0.286,1,,
Glycolysis / Gluconeogenesis - Homo sapiens (human),KEGG,1,ALDOA_HUMAN,68 (68),0.286,1,,
Prolactin,NetPath,1,JAK2_HUMAN,68 (70),0.286,1,,
Dual incision in TC-NER,Reactome,1,XPF_HUMAN,68 (69),0.286,1,,
TLR NFkB,INOH,1,PRS6A_HUMAN,69 (69),0.289,1,,
Adipocytokine signaling pathway - Homo sapiens (human),KEGG,1,JAK2_HUMAN,69 (69),0.289,1,,
superpathway of inositol phosphate compounds,HumanCyc,1,IPMK_HUMAN,69 (70),0.289,1,,
RNA polymerase II transcribes snRNA genes,Reactome,1,SNPC2_HUMAN,70 (77),0.293,1,,
p75(NTR)-mediated signaling,PID,1,RTN4_HUMAN,70 (71),0.293,1,,
Prolactin signaling pathway - Homo sapiens (human),KEGG,1,JAK2_HUMAN,70 (70),0.293,1,,
Regulation of insulin secretion,Reactome,1,CAC1E_HUMAN,70 (70),0.293,1,,
Glycolysis,Reactome,1,ALDOA_HUMAN,70 (71),0.293,1,,
KitReceptor,NetPath,1,JAK2_HUMAN,70 (70),0.293,1,,
Ub-specific processing proteases,Reactome,2,PSB11_HUMAN;PRS6A_HUMAN,220 (220),0.295,1,,
Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human),KEGG,1,RYR2_HUMAN,72 (72),0.3,1,,
p53 signaling pathway - Homo sapiens (human),KEGG,1,SESN3_HUMAN,72 (72),0.3,1,,
Parkin-Ubiquitin Proteasomal System pathway,Wikipathways,1,PRS6A_HUMAN,72 (73),0.3,1,,
Transmission across Chemical Synapses,Reactome,2,GABR2_HUMAN;CAC1E_HUMAN,224 (224),0.303,1,,
Leishmaniasis - Homo sapiens (human),KEGG,1,JAK2_HUMAN,73 (74),0.303,1,,
RMTs methylate histone arginines,Reactome,1,JAK2_HUMAN,74 (74),0.307,1,,
Inositol phosphate metabolism - Homo sapiens (human),KEGG,1,IPMK_HUMAN,74 (74),0.307,1,,
Arrhythmogenic Right Ventricular Cardiomyopathy,Wikipathways,1,RYR2_HUMAN,74 (74),0.307,1,,
Transcriptional regulation by RUNX2,Reactome,1,GLI3_HUMAN,75 (75),0.31,1,,
Formation of the cornified envelope,Reactome,1,INVO_HUMAN,75 (75),0.31,1,,
Leptin signaling pathway,Wikipathways,1,JAK2_HUMAN,76 (76),0.314,1,,
Prolactin Signaling Pathway,Wikipathways,1,JAK2_HUMAN,76 (76),0.314,1,,
Cell death signalling via NRAGE_ NRIF and NADE,Reactome,1,OBSCN_HUMAN,76 (78),0.314,1,,
Notch,INOH,1,PRS6A_HUMAN,78 (79),0.321,1,,
Cardiac muscle contraction - Homo sapiens (human),KEGG,1,RYR2_HUMAN,78 (78),0.321,1,,
Ribosome biogenesis in eukaryotes - Homo sapiens (human),KEGG,1,NXF3_HUMAN,79 (105),0.324,1,,
Organelle biogenesis and maintenance,Reactome,2,KIF17_HUMAN;RAB8A_HUMAN,237 (240),0.326,1,,
Transcription-Coupled Nucleotide Excision Repair (TC-NER),Reactome,1,XPF_HUMAN,80 (81),0.327,1,,
ECM-receptor interaction - Homo sapiens (human),KEGG,1,RELN_HUMAN,82 (82),0.334,1,,
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,1,RYR2_HUMAN,82 (82),0.334,1,,
Taste transduction - Homo sapiens (human),KEGG,1,GABR2_HUMAN,83 (83),0.337,1,,
Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human),KEGG,1,RYR2_HUMAN,83 (83),0.337,1,,
MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,1,IL6RB_HUMAN,83 (102),0.337,1,,
Global Genome Nucleotide Excision Repair (GG-NER),Reactome,1,XPF_HUMAN,84 (84),0.34,1,,
Pyrimidine metabolism,Wikipathways,1,RPC1_HUMAN,84 (84),0.34,1,,
MAPK Signaling Pathway,Wikipathways,2,PA24E_HUMAN;CAC1E_HUMAN,246 (246),0.343,1,,
CXCR4-mediated signaling events,PID,1,JAK2_HUMAN,85 (87),0.344,1,,
Insulin secretion - Homo sapiens (human),KEGG,1,RYR2_HUMAN,85 (85),0.344,1,,
Pathways in clear cell renal cell carcinoma,Wikipathways,1,ALDOA_HUMAN,85 (86),0.344,1,,
Diseases of signal transduction,Reactome,2,MPRIP_HUMAN;JAK2_HUMAN,248 (248),0.346,1,,
TP53 Regulates Metabolic Genes,Reactome,1,SESN3_HUMAN,86 (86),0.347,1,,
Regulation of PLK1 Activity at G2/M Transition,Reactome,1,RAB8A_HUMAN,87 (87),0.35,1,,
G alpha (12/13) signalling events,Reactome,1,OBSCN_HUMAN,87 (89),0.35,1,,
GABAergic synapse - Homo sapiens (human),KEGG,1,GABR2_HUMAN,88 (88),0.353,1,,
Dilated cardiomyopathy (DCM) - Homo sapiens (human),KEGG,1,RYR2_HUMAN,89 (90),0.357,1,,
Longevity regulating pathway - Homo sapiens (human),KEGG,1,SESN3_HUMAN,89 (89),0.357,1,,
Signaling by Interleukins,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,254 (254),0.357,1,,
Fc gamma R-mediated phagocytosis - Homo sapiens (human),KEGG,1,PA24E_HUMAN,90 (91),0.36,1,,
Protein digestion and absorption - Homo sapiens (human),KEGG,1,COBA2_HUMAN,90 (90),0.36,1,,
Glucose metabolism,Reactome,1,ALDOA_HUMAN,90 (91),0.36,1,,
mRNA surveillance pathway - Homo sapiens (human),KEGG,1,NXF3_HUMAN,91 (91),0.363,1,,
Morphine addiction - Homo sapiens (human),KEGG,1,GABR2_HUMAN,91 (91),0.363,1,,
Collagen formation,Reactome,1,COBA2_HUMAN,92 (92),0.366,1,,
Th1 and Th2 cell differentiation - Homo sapiens (human),KEGG,1,JAK2_HUMAN,92 (92),0.366,1,,
Corticotropin-releasing hormone signaling pathway,Wikipathways,1,INVO_HUMAN,92 (92),0.366,1,,
GnRH signaling pathway - Homo sapiens (human),KEGG,1,PA24E_HUMAN,93 (93),0.369,1,,
Phosphatidylinositol phosphate metabolism,EHMN,1,IPMK_HUMAN,93 (93),0.369,1,,
Integration of energy metabolism,Reactome,1,CAC1E_HUMAN,94 (94),0.372,1,,
Post-translational modification: synthesis of GPI-anchored proteins,Reactome,1,CD109_HUMAN,94 (95),0.372,1,,
Interferon gamma signaling,Reactome,1,JAK2_HUMAN,94 (94),0.372,1,,
Metabolism of carbohydrates,Reactome,2,ALDOA_HUMAN;CHSS3_HUMAN,263 (264),0.373,1,,
Circadian entrainment - Homo sapiens (human),KEGG,1,RYR2_HUMAN,96 (96),0.379,1,,
CD4 T cell receptor signaling-NFkB cascade,INOH,1,PRS6A_HUMAN,97 (97),0.382,1,,
Chaperonin-mediated protein folding,Reactome,1,FBXW9_HUMAN,97 (97),0.382,1,,
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,1,PA24E_HUMAN,97 (97),0.382,1,,
Anchoring of the basal body to the plasma membrane,Reactome,1,RAB8A_HUMAN,97 (97),0.382,1,,
Phosphatidylinositol signaling system - Homo sapiens (human),KEGG,1,IPMK_HUMAN,99 (99),0.388,1,,
Choline metabolism in cancer - Homo sapiens (human),KEGG,1,PA24E_HUMAN,99 (99),0.388,1,,
AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human),KEGG,1,JAK2_HUMAN,99 (99),0.388,1,,
Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,1,PA24E_HUMAN,99 (99),0.388,1,,
Respiratory electron transport,Reactome,1,NDUF5_HUMAN,100 (100),0.391,1,,
HIF-1 signaling pathway - Homo sapiens (human),KEGG,1,ALDOA_HUMAN,100 (100),0.391,1,,
Pyrimidine metabolism - Homo sapiens (human),KEGG,1,RPC1_HUMAN,101 (101),0.394,1,,
Neural Crest Differentiation,Wikipathways,1,COBA2_HUMAN,101 (101),0.394,1,,
Stimuli-sensing channels,Reactome,1,RYR2_HUMAN,102 (102),0.397,1,,
Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,2,GABR2_HUMAN;RXFP2_HUMAN,277 (277),0.398,1,,
Protein folding,Reactome,1,FBXW9_HUMAN,103 (103),0.4,1,,
Liver steatosis AOP,Wikipathways,1,NRIP1_HUMAN,103 (103),0.4,1,,
Reproduction,Reactome,1,IZUM4_HUMAN,104 (104),0.403,1,,
Antimicrobial peptides,Reactome,1,TRFL_HUMAN,104 (106),0.403,1,,
Mitotic G1-G1/S phases,Reactome,1,JAK2_HUMAN,104 (104),0.403,1,,
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,1,GSH1_HUMAN,104 (106),0.403,1,,
Senescence and Autophagy in Cancer,Wikipathways,1,IL6RB_HUMAN,105 (106),0.406,1,,
JAK-STAT,Wikipathways,1,JAK2_HUMAN,106 (106),0.409,1,,
Hemostasis,Reactome,4,ALDOA_HUMAN;CD109_HUMAN;JAK2_HUMAN;CAP1_HUMAN,662 (668),0.413,1,,
Cholinergic synapse - Homo sapiens (human),KEGG,1,JAK2_HUMAN,112 (112),0.426,1,,
Nucleotide Excision Repair,Reactome,1,XPF_HUMAN,112 (113),0.426,1,,
MAPK signaling pathway - Homo sapiens (human),KEGG,2,CAC1E_HUMAN;PA24E_HUMAN,295 (295),0.429,1,,
Phase II - Conjugation of compounds,Reactome,1,GSH1_HUMAN,113 (115),0.429,1,,
Toxoplasmosis - Homo sapiens (human),KEGG,1,JAK2_HUMAN,113 (113),0.429,1,,
Deubiquitination,Reactome,2,PSB11_HUMAN;PRS6A_HUMAN,296 (296),0.43,1,,
Innate Immune System,Reactome,6,ALDOA_HUMAN;PRS6A_HUMAN;MEFV_HUMAN;CAP1_HUMAN;TRFL_HUMAN;HMOX2_HUMAN,1067 (1077),0.431,1,,
TGF-beta super family signaling pathway canonical,INOH,1,PRS6A_HUMAN,115 (115),0.435,1,,
Serotonergic synapse - Homo sapiens (human),KEGG,1,PA24E_HUMAN,115 (115),0.435,1,,
ESC Pluripotency Pathways,Wikipathways,1,IL6RB_HUMAN,116 (116),0.438,1,,
Glycosaminoglycan metabolism,Reactome,1,CHSS3_HUMAN,119 (119),0.446,1,,
Wnt Canonical,INOH,1,PRS6A_HUMAN,119 (119),0.446,1,,
Wnt Mammals,INOH,1,PRS6A_HUMAN,119 (119),0.446,1,,
AMPK signaling pathway - Homo sapiens (human),KEGG,1,RAB8A_HUMAN,120 (120),0.449,1,,
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,1,NDUF5_HUMAN,123 (123),0.457,1,,
Platelet activation - Homo sapiens (human),KEGG,1,PA24E_HUMAN,123 (123),0.457,1,,
Integrin,INOH,1,COBA2_HUMAN,124 (124),0.46,1,,
Disease,Reactome,3,TRFL_HUMAN;MPRIP_HUMAN;JAK2_HUMAN,508 (510),0.46,1,,
Nuclear Receptors Meta-Pathway,Wikipathways,2,GSH1_HUMAN;NRIP1_HUMAN,315 (316),0.462,1,,
PDGFR-beta signaling pathway,PID,1,JAK2_HUMAN,127 (127),0.468,1,,
Keratinization,Reactome,1,INVO_HUMAN,129 (129),0.473,1,,
BCR,NetPath,1,LIME1_HUMAN,129 (129),0.473,1,,
CD4 T cell receptor signaling,INOH,1,PRS6A_HUMAN,130 (130),0.476,1,,
Relaxin signaling pathway - Homo sapiens (human),KEGG,1,RXFP2_HUMAN,130 (130),0.476,1,,
Factors involved in megakaryocyte development and platelet production,Reactome,1,JAK2_HUMAN,131 (131),0.478,1,,
Measles - Homo sapiens (human),KEGG,1,JAK2_HUMAN,131 (132),0.478,1,,
Cardiac conduction,Reactome,1,RYR2_HUMAN,131 (131),0.478,1,,
Adaptive Immune System,Reactome,4,LLR1_HUMAN;CUL3_HUMAN;FBXW9_HUMAN;SH3R1_HUMAN,722 (732),0.479,1,,
Glycerophospholipid biosynthesis,Reactome,1,PA24E_HUMAN,132 (133),0.481,1,,
Pathways in cancer - Homo sapiens (human),KEGG,3,GLI3_HUMAN;IL6RB_HUMAN;JAK2_HUMAN,525 (526),0.482,1,,
Spliceosome - Homo sapiens (human),KEGG,1,PUF60_HUMAN,133 (134),0.483,1,,
HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA),Reactome,1,XPF_HUMAN,134 (135),0.486,1,,
B cell receptor signaling,INOH,1,PRS6A_HUMAN,134 (134),0.486,1,,
Gene Silencing by RNA,Reactome,1,DDX4_HUMAN,134 (134),0.486,1,,
Pyrimidine metabolism,EHMN,1,RPC1_HUMAN,136 (136),0.491,1,,
Ubiquitin mediated proteolysis - Homo sapiens (human),KEGG,1,CUL3_HUMAN,137 (137),0.494,1,,
Apelin signaling pathway - Homo sapiens (human),KEGG,1,RYR2_HUMAN,137 (137),0.494,1,,
Estrogen signaling pathway - Homo sapiens (human),KEGG,1,GABR2_HUMAN,137 (137),0.494,1,,
G2/M Transition,Reactome,1,RAB8A_HUMAN,137 (137),0.494,1,,
Mitotic G2-G2/M phases,Reactome,1,RAB8A_HUMAN,139 (139),0.499,1,,
Ectoderm Differentiation,Wikipathways,1,GLI3_HUMAN,139 (142),0.499,1,,
PI3K-Akt Signaling Pathway,Wikipathways,2,RELN_HUMAN;JAK2_HUMAN,339 (340),0.501,1,,
Homology Directed Repair,Reactome,1,XPF_HUMAN,140 (141),0.501,1,,
Rho GTPase cycle,Reactome,1,OBSCN_HUMAN,140 (144),0.501,1,,
NRF2 pathway,Wikipathways,1,GSH1_HUMAN,142 (142),0.506,1,,
AndrogenReceptor,NetPath,1,IL6RB_HUMAN,143 (143),0.508,1,,
Cell adhesion molecules (CAMs) - Homo sapiens (human),KEGG,1,NEO1_HUMAN,144 (144),0.511,1,,
Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,1,RYR2_HUMAN,144 (144),0.511,1,,
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway,Wikipathways,1,JAK2_HUMAN,144 (144),0.511,1,,
Phospholipase D signaling pathway - Homo sapiens (human),KEGG,1,PA24E_HUMAN,145 (146),0.513,1,,
Mesodermal Commitment Pathway,Wikipathways,1,JAK2_HUMAN,146 (153),0.516,1,,
PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,2,RELN_HUMAN;JAK2_HUMAN,353 (354),0.523,1,,
Metabolism of proteins,Reactome,10,CUL3_HUMAN;DCA10_HUMAN;PRS6A_HUMAN;UROM_HUMAN;LLR1_HUMAN;PSB11_HUMAN;TIM10_HUMAN;RAB8A_HUMAN;CD109_HUMAN;FBXW9_HUMAN,1991 (2008),0.527,1,,
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,1,GABR2_HUMAN,153 (153),0.532,1,,
Hippo signaling pathway - Homo sapiens (human),KEGG,1,FRMD6_HUMAN,154 (154),0.535,1,,
Interferon Signaling,Reactome,1,JAK2_HUMAN,158 (158),0.544,1,,
Insulin Signaling,Wikipathways,1,CAP1_HUMAN,160 (160),0.549,1,,
EGF-EGFR Signaling Pathway,Wikipathways,1,JAK2_HUMAN,162 (162),0.553,1,,
Chemokine signaling pathway,Wikipathways,1,JAK2_HUMAN,165 (165),0.56,1,,
RNA transport - Homo sapiens (human),KEGG,1,NXF3_HUMAN,166 (171),0.562,1,,
DNA Double-Strand Break Repair,Reactome,1,XPF_HUMAN,168 (169),0.566,1,,
NOD-like receptor signaling pathway - Homo sapiens (human),KEGG,1,MEFV_HUMAN,168 (168),0.566,1,,
Tight junction - Homo sapiens (human),KEGG,1,RAB8A_HUMAN,170 (170),0.571,1,,
Alzheimer disease - Homo sapiens (human),KEGG,1,RTN4_HUMAN,171 (171),0.573,1,,
The citric acid (TCA) cycle and respiratory electron transport,Reactome,1,NDUF5_HUMAN,173 (173),0.577,1,,
Purine metabolism - Homo sapiens (human),KEGG,1,RPC1_HUMAN,173 (174),0.577,1,,
Axon guidance - Homo sapiens (human),KEGG,1,SEM3C_HUMAN,175 (175),0.581,1,,
Tuberculosis - Homo sapiens (human),KEGG,1,JAK2_HUMAN,178 (179),0.587,1,,
mRNA Splicing - Major Pathway,Reactome,1,PUF60_HUMAN,178 (178),0.587,1,,
Ion channel transport,Reactome,1,RYR2_HUMAN,179 (179),0.589,1,,
Vitamin D Receptor Pathway,Wikipathways,1,NRIP1_HUMAN,182 (184),0.596,1,,
Ras Signaling,Wikipathways,1,PA24E_HUMAN,184 (184),0.6,1,,
IL-7 signaling,INOH,1,JAK2_HUMAN,185 (185),0.602,1,,
EPO signaling,INOH,1,JAK2_HUMAN,186 (186),0.604,1,,
mRNA Splicing,Reactome,1,PUF60_HUMAN,186 (186),0.604,1,,
VEGF,INOH,1,JAK2_HUMAN,188 (188),0.608,1,,
Chemokine signaling pathway - Homo sapiens (human),KEGG,1,JAK2_HUMAN,189 (189),0.61,1,,
TCF dependent signaling in response to WNT,Reactome,1,CUL3_HUMAN,189 (190),0.61,1,,
Peptide ligand-binding receptors,Reactome,1,RXFP2_HUMAN,194 (194),0.619,1,,
Focal Adhesion,Wikipathways,1,RELN_HUMAN,198 (198),0.627,1,,
Focal adhesion - Homo sapiens (human),KEGG,1,RELN_HUMAN,199 (199),0.629,1,,
Epstein-Barr virus infection - Homo sapiens (human),KEGG,1,PRS6A_HUMAN,200 (201),0.631,1,,
Viral carcinogenesis - Homo sapiens (human),KEGG,1,IL6RB_HUMAN,201 (201),0.632,1,,
Ciliary landscape,Wikipathways,1,RAB8A_HUMAN,213 (213),0.654,1,,
Phospholipid metabolism,Reactome,1,PA24E_HUMAN,215 (216),0.657,1,,
Cytokine Signaling in Immune system,Reactome,2,IL6RB_HUMAN;JAK2_HUMAN,458 (458),0.665,1,,
Purine metabolism,EHMN,1,RPC1_HUMAN,223 (223),0.671,1,,
GPCR ligand binding,Reactome,2,GABR2_HUMAN;RXFP2_HUMAN,465 (466),0.673,1,,
Biological oxidations,Reactome,1,GSH1_HUMAN,229 (231),0.681,1,,
Thermogenesis - Homo sapiens (human),KEGG,1,NDUF5_HUMAN,229 (229),0.681,1,,
Ras signaling pathway - Homo sapiens (human),KEGG,1,PA24E_HUMAN,232 (232),0.685,1,,
TNFalpha,NetPath,1,PRS6A_HUMAN,234 (234),0.689,1,,
Cell Cycle_ Mitotic,Reactome,2,RAB8A_HUMAN;JAK2_HUMAN,479 (481),0.689,1,,
Processing of Capped Intron-Containing Pre-mRNA,Reactome,1,PUF60_HUMAN,240 (240),0.698,1,,
Endocytosis - Homo sapiens (human),KEGG,1,RAB8A_HUMAN,244 (244),0.704,1,,
Infectious disease,Reactome,1,TRFL_HUMAN,251 (253),0.714,1,,
miR-targeted genes in epithelium - TarBase,Wikipathways,1,RTN4_HUMAN,267 (333),0.736,1,,
Chromatin modifying enzymes,Reactome,1,JAK2_HUMAN,271 (272),0.742,1,,
Chromatin organization,Reactome,1,JAK2_HUMAN,271 (272),0.742,1,,
Signaling by WNT,Reactome,1,CUL3_HUMAN,277 (278),0.749,1,,
Asparagine N-linked glycosylation,Reactome,1,UROM_HUMAN,286 (286),0.76,1,,
Metabolism,Reactome,8,PA24E_HUMAN;ALDOA_HUMAN;GSH1_HUMAN;CHSS3_HUMAN;IPMK_HUMAN;CAC1E_HUMAN;HMOX2_HUMAN;NDUF5_HUMAN,1954 (1972),0.767,1,,
Extracellular matrix organization,Reactome,1,COBA2_HUMAN,293 (294),0.769,1,,
Cytokine-cytokine receptor interaction - Homo sapiens (human),KEGG,1,IL6RB_HUMAN,294 (294),0.77,1,,
Cell Cycle,Reactome,2,RAB8A_HUMAN;JAK2_HUMAN,562 (564),0.771,1,,
Membrane Trafficking,Reactome,2,RAB8A_HUMAN;DEN5B_HUMAN,582 (582),0.788,1,,
DNA Repair,Reactome,1,XPF_HUMAN,318 (320),0.796,1,,
miR-targeted genes in muscle cell - TarBase,Wikipathways,1,RTN4_HUMAN,329 (400),0.807,1,,
Class A/1 (Rhodopsin-like receptors),Reactome,1,RXFP2_HUMAN,330 (330),0.808,1,,
Gene expression (Transcription),Reactome,5,RPC1_HUMAN;GLI3_HUMAN;SNPC2_HUMAN;DDX4_HUMAN;SESN3_HUMAN,1360 (1373),0.814,1,,
Human papillomavirus infection - Homo sapiens (human),KEGG,1,RELN_HUMAN,339 (339),0.817,1,,
Vesicle-mediated transport,Reactome,2,RAB8A_HUMAN;DEN5B_HUMAN,620 (620),0.817,1,,
GPCR downstream signalling,Reactome,4,GABR2_HUMAN;OBSCN_HUMAN;RXFP2_HUMAN;JAK2_HUMAN,1172 (1176),0.841,1,,
Transcriptional Regulation by TP53,Reactome,1,SESN3_HUMAN,372 (374),0.845,1,,
Transport of small molecules,Reactome,2,HMOX2_HUMAN;RYR2_HUMAN,665 (666),0.847,1,,
G alpha (i) signalling events,Reactome,1,GABR2_HUMAN,399 (400),0.865,1,,
Signaling by GPCR,Reactome,4,GABR2_HUMAN;OBSCN_HUMAN;RXFP2_HUMAN;JAK2_HUMAN,1235 (1240),0.87,1,,
Signaling by Receptor Tyrosine Kinases,Reactome,1,JAK2_HUMAN,423 (423),0.881,1,,
Signaling by Rho GTPases,Reactome,1,OBSCN_HUMAN,431 (435),0.885,1,,
Signal Transduction,Reactome,9,GABR2_HUMAN;OBSCN_HUMAN;CUL3_HUMAN;JAK2_HUMAN;GLI3_HUMAN;IL6RB_HUMAN;RTN4_HUMAN;PTPRA_HUMAN;RXFP2_HUMAN,2634 (2647),0.925,1,,
Metabolism of RNA,Reactome,1,PUF60_HUMAN,577 (586),0.946,1,,
G alpha (s) signalling events,Reactome,1,RXFP2_HUMAN,581 (583),0.947,1,,
RNA Polymerase II Transcription,Reactome,3,GLI3_HUMAN;SNPC2_HUMAN;SESN3_HUMAN,1223 (1236),0.948,1,,
Metabolism of lipids,Reactome,1,PA24E_HUMAN,660 (664),0.965,1,,
Generic Transcription Pathway,Reactome,2,GLI3_HUMAN;SESN3_HUMAN,1101 (1107),0.976,1,,